Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SURGERY PARTNERS, INC.

(SGRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Surgery Partners, Inc.(NasdaqGS:SGRY) dropped from Russell 3000E Index

06/25/2021 | 12:00am EDT

Surgery Partners, Inc.(NasdaqGS:SGRY) dropped from Russell 3000E Index


© S&P Capital IQ 2021
All news about SURGERY PARTNERS, INC.
09/10SURGERY PARTNERS : Cowen Starts Surgery Partners at Market Perform with $50 Pric..
MT
08/17SURGERY PARTNERS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
08/16SURGERY PARTNERS : Investor Presentation - August 2021 (PDF)
PU
08/04SURGERY PARTNERS : Management's Discussion and Analysis of Financial Condition a..
AQ
08/04Tranche Update on Surgery Partners, Inc.'s Equity Buyback Plan announced on D..
CI
08/04SURGERY PARTNERS : Posts Narrower Q2 Loss on Higher Revenue; Reiterates FY21 Gui..
MT
08/04SURGERY PARTNERS : Q2 Earnings Snapshot
AQ
08/04SURGERY PARTNERS : ANNOUNCES SECOND QUARTER 2021 RESULTS (Form 8-K)
PU
08/04SURGERY PARTNERS, INC. : Results of Operations and Financial Condition (form 8-K..
AQ
08/04SURGERY PARTNERS : Announces Second Quarter 2021 Results
AQ
More news
Analyst Recommendations on SURGERY PARTNERS, INC.
More recommendations
Financials (USD)
Sales 2021 2 217 M - -
Net income 2021 -16,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -47,0x
Yield 2021 -
Capitalization 3 768 M 3 768 M -
Capi. / Sales 2021 1,70x
Capi. / Sales 2022 1,55x
Nbr of Employees 9 950
Free-Float 38,7%
Chart SURGERY PARTNERS, INC.
Duration : Period :
Surgery Partners, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SURGERY PARTNERS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 46,50 $
Average target price 63,57 $
Spread / Average Target 36,7%
EPS Revisions
Managers and Directors
J. Eric Evans Chief Executive Officer & Director
Thomas F. Cowhey CFO, Principal Accounting Officer & Executive VP
Wayne S. DeVeydt Executive Chairman
Varun Gadhok Chief Information Officer & Senior Vice President
Roxanne Womack Chief Compliance Officer & Senior Vice President
Sector and Competitors